Cargando…
Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
Liver fibrosis, which is characterized by the excessive deposition of extracellular matrix (ECM) materials (primarily fibrillar collagen-I), is an abnormal repair reaction and pathological outcome of chronic liver diseases caused by alcohol abuse, non-alcoholic fatty liver disease, and chronic hepat...
Autores principales: | Li, Le, Zhu, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871257/ https://www.ncbi.nlm.nih.gov/pubmed/36703745 http://dx.doi.org/10.3389/fphar.2022.1071844 |
Ejemplares similares
-
Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023) -
Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer
por: Huang, Chen, et al.
Publicado: (2022) -
Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway
por: Xu, Lenan, et al.
Publicado: (2023) -
Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
por: Zhang, Le, et al.
Publicado: (2022) -
Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)